Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months
Clinical trial NCT03020628 · COMPLETED
Trial details
- NCT number
- NCT03020628
- Sponsor
- SK Chemicals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-03-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.